|
2024
|
G/S
|
Sanitary preparations for medical purposes; plasters,
materials for dressings; material for dent... |
|
|
G/S
|
Amino acids for medical purposes; analgesics; antibiotics;
antiseptics; diagnostic biomarker rea... |
|
|
G/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations. |
|
|
G/S
|
Pharmaceutical preparations; medical and veterinary
preparations; dietetic food and substances a... |
|
|
Invention
|
Monoclonal antibody or antigen-binding fragment thereof that specifically binds to axl, and use t... |
|
|
G/S
|
Protein preparations for use as additives to foodstuffs for
human consumption for medical purpos... |
|
|
G/S
|
Albuminous preparations for medical purposes; biological
preparations for medical purposes; prep... |
|
|
Invention
|
Isolated bispecific antibody that specifically binds to cd3 and tumor antigen, and use thereof. T... |
|
|
Invention
|
Antibody-like molecule comprising heterodimer of human cd1b (cluster of differentiation 1) protei... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; hygienic
preparations for medical purposes; dietetic... |
|
2023
|
Invention
|
Pharmaceutical composition of non-enveloped virus. The present invention relates to the field of ... |
|
|
Invention
|
Cyclin-dependent kinase 7 inhibitors. The present invention relates to novel compounds of formula... |
|
|
Invention
|
Method for treating a t-lymphocyte-mediated disease. The present invention relates to the field o... |
|
|
Invention
|
Pharmaceutical composition of anti-cd20 antibody and use thereof. The present invention relates t... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Nucleic acid having promoter activity and use thereof. The present application relates to the fie... |
|
|
Invention
|
Monoclonal antibody or antigen-binding fragment thereof that specifically binds to bcma, and use ... |
|
|
Invention
|
Isolated nucleic acid that encodes fusion protein based on fviii-bdd and on heterologous signal p... |
|
|
Invention
|
Codon-optimized nucleic acid encoding the fviii-bdd. The present application relates to the field... |
|
|
Invention
|
Cardboard pharmaceutical packaging container. The invention relates to a pharmaceutical packaging... |
|
|
G/S
|
Pharmaceuticals and veterinary products; sanitary
preparations for medical purposes; dietetic su... |
|
|
Invention
|
Pharmaceutical composition of anti-trbv9 antibody and use thereof. The invention relates to the f... |
|
|
Invention
|
Monoclonal antibodies and methods for using same.
The invention relates to monoclonal antibodies... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of multiple
sclerosis. |
|
2022
|
Invention
|
Monoclonal antibody or antigen-binding fragment thereof that specifically binds to il-4ra, and us... |
|
|
Invention
|
Bispecific antibody comprising a heterodimer based on mhc proteins. The present invention relates... |
|
|
Invention
|
Inducible promoter, vector and host cell based thereon. The present invention relates to the fiel... |
|
|
Invention
|
Isolated modified aav9 capsid protein vp1.
The present application relates to the fields of gene... |
|
|
Invention
|
Isolated modified capsid protein vp1 from adeno-associated virus serotype 5 (aav5), capsid and ve... |
|
|
Invention
|
Isolated modified aav5 capsid protein vp1. The present application relates to the field of gene t... |
|
|
Invention
|
Isolated modified aav9 capsid protein vp1. The present application relates to the fields of gene ... |
|
|
Invention
|
Isolated modified aav9 capsid protein vp1. The present application relates to the field of gene t... |
|
|
Invention
|
Method for producing modified adeno-associated virus capsid. The present application relates to t... |
|
|
Invention
|
Method of obtaining a modified adeno-associated virus capsid. The present application relates to ... |
|
|
Invention
|
Isolated bispecific antibody that specifically binds to cd47 and pd-l1. The present invention rel... |
|
|
Invention
|
Influenza virus-based isolated recombinant virus. The present invention relates to the fields of ... |
|
|
Invention
|
Pharmaceutical composition of pembrolizumab and use thereof. The invention relates to the field o... |
|
|
Invention
|
Malignant neoplasis treatment using pd-1 antibody combination. The present invention relates to t... |
|
|
Invention
|
Monoclonal antibody that specifically binds to gd2. The present invention relates to the field of... |
|
|
Invention
|
Codon-optimized nucleic acid encoding the fix protein.
The present application relates to the fi... |
|
|
Invention
|
Codon-optimized nucleic acid encoding the fix protein. The present application relates to the fie... |
|
|
Invention
|
Synergistic effect of smn1 and mir-23a in treating spinal muscular atrophy.
The present applicat... |
|
|
Invention
|
Synergistic effect of smn1 and mir-23a in treating spinal muscular atrophy. The present applicati... |
|
2021
|
Invention
|
Epidermal growth factor receptor inhibitors. The present invention relates to novel compounds of ... |
|
|
Invention
|
Aav5-based vaccine for induction of specific immunity and/or prevention of sars-cov-2-related inf... |
|
|
Invention
|
Immunocytokine for activating human il-10ra receptor and use thereof.
The present invention rela... |
|
|
Invention
|
Immunocytokine for activating human il-10ra receptor and use thereof. The present invention relat... |
|
|
Invention
|
Aav5-based vaccine against sars-cov-2.
The present application relates to the fields of biotechn... |
|
|
Invention
|
Aqueous pharmaceutical composition of levilimab.
The disclosure relates to the field of pharmacy... |
|
2020
|
Invention
|
Immunocytokine comprising heterodymeric protein complex based on il-15/il-15ra.
The present inve... |
|
|
G/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations; chemical preparations for medi... |
|
|
Invention
|
Isolated modified vp1 capsid protein of aav5.
This application relates to the fields of gene the... |
|
|
Invention
|
Use of cas9 protein from the bacterium pasteurella pneumotropica.
The present invention describe... |
|
|
Invention
|
Dna-cutting agent based on cas9 protein from the bacterium pasteurella pneumotropica.
The presen... |
|
|
Invention
|
Monoclonal antibody that binds specifically to gitr.
The present invention relates to biotechnol... |
|
|
Invention
|
Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof.
The present disclo... |
|
2019
|
G/S
|
Vitamins for the food industry; vitamins for use in the
manufacture of food supplements; vitamin... |
|
|
G/S
|
Albuminous preparations for medical purposes;
bacteriological preparations for medical and veter... |
|
2018
|
G/S
|
Pharmaceutical preparations for the treatment of the lung
cancer. |
|
|
G/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations; biological preparations for me... |
|
|
G/S
|
Pharmaceutical products; pharmaceutical preparations;
medical and veterinary preparations; sanit... |
|
2017
|
G/S
|
Pharmaceuticals; medical and veterinary preparations;
sanitary preparations for medical purposes... |
|
|
G/S
|
Pharmaceutical preparations; sanitary preparations for
medical purposes; dietetic food and subst... |
|
2016
|
G/S
|
Chemicals used in industry and science. Pharmaceutical preparations; sanitary preparations for
m... |
|
2012
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations;
dietetic substances adapted for medical us... |
|
2008
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
G/S
|
Bacterial preparations for veterinary use, albuminous
preparations for medical purposes, veterin... |
